Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.
about
Incidence of Tuberculosis among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy in Europe and North AmericaEmergence of drug resistance is associated with an increased risk of death among patients first starting HAARTLife expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studiesSuccessful cognitive aging in persons living with HIV infectionTiming of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studiesAIDS-defining illnesses among patients with HIV in Singapore, 1985 to 2001: results from the Singapore HIV Observational Cohort Study (SHOCS)Viral load responses to HAART is an independent predictor of a new AIDS event in late stage HIV infected patients: prospective cohort study.Modelling the impact of antiretroviral use in resource-poor settingsThe 2015 Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS in HIV-Infected KoreansSuccessful cognitive aging and health-related quality of life in younger and older adults infected with HIVDoes HIV infection have an impact upon dental implant osseointegration? A systematic reviewAntiretroviral therapy for prevention of HIV transmission: implications for EuropeHIV Infection in the Elderly: Arising ChallengesStrengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaborationImpact of Socioeconomic Inequality on Access, Adherence, and Outcomes of Antiretroviral Treatment Services for People Living with HIV/AIDS in VietnamAge at Entry Into Care, Timing of Antiretroviral Therapy Initiation, and 10-Year Mortality Among HIV-Seropositive Adults in the United StatesLate HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996-2004Relationship between CD4+ T-cell counts/HIV-1 RNA plasma viral load and AIDS-defining events among persons followed in the ACTG longitudinal linked randomized trials studyEffectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for UkraineA complex systems approach to evaluate HIV prevention in metropolitan areas: preliminary implications for combination intervention strategiesThe potential impact of pre-exposure prophylaxis for HIV prevention among men who have sex with men and transwomen in Lima, Peru: a mathematical modelling studyFeasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study)Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluationSwitching HIV treatment in adults based on CD4 count versus viral load monitoring: a randomized, non-inferiority trial in ThailandIllicit drug use is a significant risk factor for loss to follow up in patients with HIV-1 infection at a large urban HIV clinic in TokyoDeterminants of progression to AIDS and death following HIV diagnosis: a retrospective cohort study in Wuhan, ChinaEfficacy of initial antiretroviral therapy for HIV-1 infection in adults: a systematic review and meta-analysis of 114 studies with up to 144 weeks' follow-upEffectiveness and cost effectiveness of oral pre-exposure prophylaxis in a portfolio of prevention programs for injection drug users in mixed HIV epidemicsMortality, Causes of Death and Associated Factors Relate to a Large HIV Population-Based CohortCause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral TherapyInteractive Data Visualization for HIV Cohorts: Leveraging Data Exchange Standards to Share and Reuse Research ToolsKericho CLinic-based ART Diagnostic Evaluation (CLADE): design, accrual, and baseline characteristics of a randomized controlled trial conducted in predominately rural, district-level, HIV clinics of KenyaOn the Use of Fractional Polynomial Models to Assess Preventive Aspect of Variables: An Example in Prevention of Mortality Following HIV InfectionEvaluation of portable point-of-care CD4 counter with high sensitivity for detecting patients eligible for antiretroviral therapyPre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV diseaseMortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the CaribbeanManaging the Personal Side of Health Care among Patients with HIV/AIDS.Initiation of antiretroviral therapy.A novel experimental model of Cryptococcus neoformans-related immune reconstitution inflammatory syndrome (IRIS) provides insights into pathogenesis.Cost-effectiveness of managing HIV infection.
P2860
Q21521430-8926AFA1-5C62-42DB-A13D-9A01C6CA895FQ21563427-B5FD4DDE-A021-4BBB-ADBC-5227A0083D87Q24597052-F01B6475-FC4E-4430-AB92-57F19C52411EQ24631698-3B65827C-B06A-4BB3-AAE7-1C306C4AADBEQ24656950-EA618AE2-4CAF-48E8-AB91-2545D13ABE00Q24802044-FDF616F1-4F7F-4D9C-BF9C-941FABCECDE7Q24814489-C682ADFC-AC7C-4A89-95B2-939D980B7A85Q25255753-E1FE29C1-CE1C-4E53-BF57-32B91A5205D2Q26781379-D4E10B05-8420-414E-AF13-7A38ADE4CA2FQ27000425-1635C509-551E-49CD-95EA-6703AFB02D60Q27021653-F14B0FF3-9D17-4D0E-B16D-35F592CC1CD2Q27023464-061955EB-107F-4907-BA82-27EAFACF8F2CQ28076000-9D5FC556-AFB5-41AB-B542-93DD9EBC45BEQ28222847-97889C5F-08B6-4331-9FD4-0CDC023F58A8Q28354164-A0EF3534-C6AD-4E6F-8362-DDAFFD725BC2Q28387887-D4DA4D39-91D5-4333-B515-C397665C8E25Q28474749-778A32F7-2962-4403-BD23-99DCFCC2BB01Q28475281-877BF2E8-B2DD-495B-96F6-4493A8481D35Q28477312-E94D6355-B7AF-4871-A6B8-D6A5C1C5D0DEQ28483747-F9E00504-4A69-4F10-AA86-F0152AB86CD8Q28484308-3F7F2DEB-E4CB-4060-9F36-113965D94D0DQ28485122-AB4FFF32-DD2D-4634-90DC-2AAEE9545400Q28485280-83DD09DA-825E-49F7-BF68-34A61EAA8EF4Q28535141-93367244-0C9B-4245-A736-C241C180F4C2Q28535181-3A7915C4-39E8-4673-B3F8-F3726CA93656Q28537961-455BB61C-A871-42C0-927F-F6A91DF4377DQ28538860-0ACB149C-AD1C-455F-A9CE-DCE93EC24988Q28539234-A5DBEDDF-7EDD-4052-94BB-26DE492DEA89Q28551895-0C6BE89F-B6A7-4D4E-BBB5-DC7B789B8B8DQ28553516-A3C943B8-4F3C-4387-B8D5-29DDFE63C83BQ28602925-8494BD98-1DAB-4729-BEC2-316A5A4D8F61Q28649524-ECCFA191-6211-4B5E-A390-F7BE68DD5A48Q28704413-58584EB2-2A11-4F32-83A2-45D1AAF7C197Q28730448-1D9E7F48-4809-4FB3-B141-9305F3A4726FQ28731034-D4D5FDE5-C2A2-47D6-B073-5D1BEEF783C9Q28749991-5B686CBA-AC48-4740-8B49-0F83A0FD4078Q30207536-F8C0B120-F9E2-4539-9F15-9349F4DB9847Q30209635-65F49744-05CE-4A47-A332-83F51C268257Q30379272-544646B7-0E50-40A1-B988-A6B7F2CED0A4Q30381397-D3C758F6-1629-4348-A785-0393086C73DF
P2860
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Prognosis of HIV-1-infected pa ...... alysis of prospective studies.
@ast
Prognosis of HIV-1-infected pa ...... alysis of prospective studies.
@en
Prognosis of HIV-1-infected pa ...... alysis of prospective studies.
@nl
type
label
Prognosis of HIV-1-infected pa ...... alysis of prospective studies.
@ast
Prognosis of HIV-1-infected pa ...... alysis of prospective studies.
@en
Prognosis of HIV-1-infected pa ...... alysis of prospective studies.
@nl
prefLabel
Prognosis of HIV-1-infected pa ...... alysis of prospective studies.
@ast
Prognosis of HIV-1-infected pa ...... alysis of prospective studies.
@en
Prognosis of HIV-1-infected pa ...... alysis of prospective studies.
@nl
P2093
P50
P1433
P1476
Prognosis of HIV-1-infected pa ...... alysis of prospective studies.
@en
P2093
ART Cohort Collaboration
Amy C Justice
Andrew N Phillips
Antonella D'Arminio Monforte
Bernd Salzberger
Bruno Ledergerber
Catherine Leport
Frank de Wolf
Jonathan A C Sterne
Peter Reiss
P304
P356
10.1016/S0140-6736(02)09411-4
P407
P50
P577
2002-07-01T00:00:00Z